These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32052794)

  • 1. Effect of Grilled Nux Vomica on Differential RNA Expression Profile of Gastrocnemius Muscle and Toll‑Like Receptor 4 (TLR-4)/Nuclear Factor kappa B (NF-κB) Signaling in Experimental Autoimmune Myasthenia Gravis Rats.
    Jiang XH; Chen Y; Ding YY; Qiu H; Zhou DY; Qiu CL
    Med Sci Monit; 2020 Feb; 26():e919150. PubMed ID: 32052794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
    Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
    Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tetramethylpyrazine attenuates experimental autoimmune myasthenia gravis in rats via regulating related cytokines and antibodies].
    Ren Y; Zhang B; Jia D; Hu K
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov; 32(11):1471-1474. PubMed ID: 27774937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.
    Wang HB; Shi FD; Li H; van der Meide PH; Ljunggren HG; Link H
    Clin Immunol; 2000 May; 95(2):156-62. PubMed ID: 10779409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of experimental autoimmune myasthenia gravis rats with FTY720 and its effect on Th1/Th2 cells.
    Huang J; Zhang T; Wang H; Zhao Y
    Mol Med Rep; 2018 May; 17(5):7409-7414. PubMed ID: 29568889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydroartemisinin ameliorates experimental autoimmune myasthenia gravis by regulating CD4
    Li Y; Shan Y; Xu L; Chen W; Li Y
    Int Immunopharmacol; 2024 Sep; 139():112699. PubMed ID: 39024745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qiangji Jianli Decoction promotes mitochondrial biogenesis in skeletal muscle of myasthenia gravis rats via AMPK/PGC-1α signaling pathway.
    Jiao W; Hu F; Li J; Song J; Liang J; Li L; Song Y; Chen Z; Li Q; Ke L
    Biomed Pharmacother; 2020 Sep; 129():110482. PubMed ID: 32768964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine receptor-specific immunosuppressive therapy of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Luo J; Lindstrom J
    Ann N Y Acad Sci; 2018 Feb; 1413(1):76-81. PubMed ID: 29377167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis.
    Feferman T; Maiti PK; Berrih-Aknin S; Bismuth J; Bidault J; Fuchs S; Souroujon MC
    J Immunol; 2005 May; 174(9):5324-31. PubMed ID: 15843529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3.
    Feferman T; Aricha R; Mizrachi K; Geron E; Alon R; Souroujon MC; Fuchs S
    J Neuroimmunol; 2009 Apr; 209(1-2):87-95. PubMed ID: 19232748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR.
    Zhang GX; Xiao BG; Yu LY; van der Meide PH; Link H
    J Neuroimmunol; 2001 Feb; 113(1):10-8. PubMed ID: 11137572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment.
    Zhou Y; Kaminski HJ; Gong B; Cheng G; Feuerman JM; Kusner L
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4348-59. PubMed ID: 24917137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibiton of STAT3.
    Wang CC; Zhang M; Li H; Li XL; Yue LT; Zhang P; Liu RT; Chen H; Li YB; Duan RS
    Neurosci Lett; 2017 Aug; 656():169-176. PubMed ID: 28743581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low and high doses of ursolic acid ameliorate experimental autoimmune myasthenia gravis through different pathways.
    Xu H; Zhang M; Li XL; Li H; Yue LT; Zhang XX; Wang CC; Wang S; Duan RS
    J Neuroimmunol; 2015 Apr; 281():61-7. PubMed ID: 25867469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen-specific immunotherapeutic vaccine for experimental autoimmune myasthenia gravis.
    Luo J; Lindstrom J
    J Immunol; 2014 Nov; 193(10):5044-55. PubMed ID: 25288571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway.
    Wang CC; Li H; Zhang M; Li XL; Yue LT; Zhang P; Zhao Y; Wang S; Duan RN; Li YB; Duan RS
    J Neuroinflammation; 2015 Jun; 12():118. PubMed ID: 26071315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific immunotherapy of experimental myasthenia gravis by a novel mechanism.
    Luo J; Kuryatov A; Lindstrom JM
    Ann Neurol; 2010 Apr; 67(4):441-51. PubMed ID: 20437579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
    Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
    Ma CG; Zhang GX; Xiao BG; Link H
    Clin Exp Immunol; 1996 Jun; 104(3):509-16. PubMed ID: 9099937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of an miR155 inhibitor by anti-CD20 single-chain antibody into B cells reduces the acetylcholine receptor-specific autoantibodies and ameliorates experimental autoimmune myasthenia gravis.
    Wang YZ; Tian FF; Yan M; Zhang JM; Liu Q; Lu JY; Zhou WB; Yang H; Li J
    Clin Exp Immunol; 2014 May; 176(2):207-21. PubMed ID: 24387321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.